Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 250.00
0.00 (0.00%)
Sep 16, 2026, 3:30 PM JST
Transgenic Group Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 4,163 | 4,263 | 3,048 | 3,999 | 5,597 | 7,148 | |
Market Cap Growth | 12.61% | 39.89% | -23.79% | -28.55% | -21.70% | -32.42% |
Enterprise Value | 4,564 | 4,967 | 3,408 | 3,971 | 4,855 | 5,404 |
Last Close Price | 250.00 | 256.00 | 183.00 | 241.00 | 328.09 | 413.77 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 126.16 | - | - | 999.77 | - | 3.81 |
Forward PE | - | 14.76 | 14.76 | 14.76 | 14.76 | 14.76 |
PS Ratio | 0.31 | 0.32 | 0.23 | 0.31 | 0.49 | 0.57 |
PB Ratio | 0.84 | 0.88 | 0.63 | 0.67 | 0.91 | 1.08 |
P/TBV Ratio | 0.95 | 1.00 | 0.72 | 0.75 | 1.03 | 1.16 |
P/FCF Ratio | - | - | - | - | - | 5.69 |
P/OCF Ratio | 166.53 | 170.53 | 32.42 | - | - | 4.00 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.33 | 0.38 | 0.26 | 0.30 | 0.43 | 0.43 |
EV/EBITDA Ratio | 11.69 | 16.95 | - | 15.82 | 30.92 | 2.62 |
EV/EBIT Ratio | 17.76 | 35.99 | - | 38.93 | - | 2.94 |
EV/FCF Ratio | - | - | - | - | - | 4.30 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.53 | 0.43 | 0.53 | 0.38 | 0.40 | 0.27 |
Debt / EBITDA Ratio | 6.67 | 7.13 | - | 8.98 | 15.39 | 0.88 |
Debt / FCF Ratio | - | - | - | - | - | 1.45 |
Net Debt / Equity Ratio | 0.07 | -0.01 | 0.00 | -0.04 | -0.17 | -0.42 |
Net Debt / EBITDA Ratio | 0.88 | -0.16 | -1.36 | -0.89 | -6.64 | -1.36 |
Net Debt / FCF Ratio | - | 1.07 | -0.23 | 0.34 | 0.60 | -2.23 |
Asset Turnover | 1.40 | 1.36 | 1.34 | 1.28 | 1.08 | 1.30 |
Inventory Turnover | 4.47 | 4.58 | 4.87 | 4.85 | 4.78 | 5.79 |
Quick Ratio | 0.95 | 0.86 | 1.15 | 1.57 | 1.65 | 2.07 |
Current Ratio | 1.75 | 1.74 | 2.05 | 2.69 | 2.76 | 2.90 |
Return on Equity (ROE) | 0.57% | -2.00% | -20.07% | 0.07% | -6.88% | 31.87% |
Return on Assets (ROA) | 1.65% | 0.89% | -1.64% | 0.62% | -0.15% | 11.86% |
Return on Invested Capital (ROIC) | 5.10% | 2.85% | -4.79% | 0.18% | -0.56% | 31.55% |
Return on Capital Employed (ROCE) | 4.40% | 2.30% | -4.00% | 1.40% | -0.30% | 23.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.79% | -1.81% | -35.73% | 0.10% | -7.31% | 26.25% |
FCF Yield | -1.03% | -1.01% | -2.66% | -16.40% | -31.02% | 17.59% |
Dividend Yield | - | - | - | 1.24% | 0.91% | 0.73% |
Payout Ratio | - | - | - | 2075.00% | - | 2.77% |
Buyback Yield / Dilution | -0.03% | -0.12% | 1.00% | 0.25% | 1.87% | 1.18% |
Total Shareholder Return | -0.03% | -0.12% | 1.00% | 1.49% | 2.79% | 1.91% |